A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature

Table 1

Tabular description of patient demographics and dosing for each contrast agent. No significant difference in patient age or weight between groups. Statistically significant dose difference (∗) is calculated based on dose relative to “standard dose” of 0.03 mmol/kg gadofosveset trisodium and 0.1 mmol/kg gadobenate dimeglumine.

	Gadofosveset	Gadobenate	𝑃-value
Number of patients	20	20	N/A
Gender	15 M/5 F	9 M/11 F	N/A
Average age—years (SD)	39 (15)	44 (17)	0.40
Average weight—kg (SD)	81 (17)	79 (26)	0.75
Average dose—mmol/kg (SD)	0.033 (0.006)	0.137 (0.033)	0.003*